Pat1 is a hub for mRNA metabolism, acting in pre-mRNA splicing, translation repression 24 and mRNA decay. A critical step in all 5'-3' mRNA decay pathways is removal of the 5' 25 cap structure, which precedes and permits digestion of the RNA body by conserved 26 exonucleases. During bulk 5'-3' decay, the Pat1/Lsm1-7 complex engages mRNA at the 27 3' end and promotes hydrolysis of the cap structure by Dcp1/Dcp2 at the 5' end through 28 an unknown mechanism. We reconstitute Pat1 with 5' and 3' decay factors and show 29
INTRODUCTION 38
Proper degradation of mRNA transcripts shapes the timing and quantity of gene 39 expression to regulate a diverse array of cellular processes (1, 2). Cleavage of the 5' 40 m 7 G cap (decapping) removes the mRNA from the translating pool and exposes a free 41 monophosphate which leads to rapid degradation by the 5'-3' exonuclease Xrn1(2, 3). 42
Decapping is a critical process for establishing 5'-3' mRNA degradation and is found in 43 bulk mRNA decay, clearance of maternal transcripts, quality control pathways, and 44 question is how Pat1 coordinates assembly of Lsm1-7 complex on the mRNA 3' end 67 with decapping at the 5' end. 68 69 Pat1 is conserved from yeast to humans and contains three domains that interact with 70 distinct decay factors. The disordered N-terminal region of Pat1 contains a conserved 71 motif that interacts with the DEAD-box ATPase Dhh1, but is generally dispensable for 72 cell growth and normal mRNA turnover (35, 36) . The a-a superhelical C-terminal 73 domain (PatC) interacts with Lsm1-7, which is required for bulk 5'-3' mRNA degradation 74 in vivo (27, 28, (37) (38) (39) . Removal of the unstructured middle domain severely attenuates 75 decapping and 5'-3' degradation, though the mechanism remains poorly understood 76 (36, 40). The conservation of the middle and C-terminal domains from yeast to humans 77 suggests they are critical for decapping and proper mRNA decay, but how these 78 domains interact with and activate mRNA decay factors remains unknown. 79 80 Here, we determine how Pat1 interacts with and activates both the Lsm1-7 complex and 81 Dcp1/Dcp2 from the fission yeast S.pombe (Sp) using recombinant purified proteins, 82 which recapitulate the regulation of decapping observed in budding yeast (16, 17) . We 83
show that Pat1 promotes RNA binding of the Lsm1-7 complex using two short linear 84 motifs from its middle domain that make physical interactions with the Lsm1-7 ring and 85 enhance its interaction with RNA. Pat1 activates decapping using its middle domain and 86 structured C-terminus, which directly binds conserved helical leucine motifs in Dcp2, to 87 alleviate autoinhibition and promote substrate binding. Our results reveal how Pat1 88 nucleates assembly of a decapping mRNP and uses distinct domains to activate decay 89 factors at both the 3' and 5' ends of a transcript to promote mRNA degradation. 90
91

RESULTS 92
Pat1 makes bipartite interactions with Lsm1-7 to enhance RNA binding 93
Previous studies of Pat1 and Lsm1-7 purified from budding yeast indicate Pat1 is 94 necessary to promote high affinity interactions with Lsm1-7 and RNA, and that the 95 middle and C-terminal domains of Pat1 are sufficient to complement growth defects in 96 strains where Pat1 is deleted (36, 37). To understand the domains of Pat1 involved in 97 mRNA turnover in S. pombe, we constructed strains harboring different domain 98 deletions of Pat1 (Fig. 1A) . Both full length Pat1 and PatMC (residues 296-754) were 99 sufficient to compliment the growth defect in the ∆Pat1 strain. Neither the middle nor C-100 terminal domain alone, however, could rescue growth, which was not due to a protein 101 expression defect ( Fig. 1B,C) . This suggests that, like budding yeast, both the middle 102 and C-terminal domains of Pat1 are required for normal mRNA turnover in S.pombe. 103
104
To better understand how individual domains of Pat1 function in complex with Lsm1-7, 105 we purified Maltose Binding Protein (MBP) fusions of different fission yeast Pat1 106 constructs and queried if they could enhance RNA binding of the Lsm1-7 complex. We 107 used fluorescence polarization with an rA15 probe (termed oligoA), which mimics a 108 deadenylated tail, to measure RNA binding and examined which regions of Pat1 could 109 enhance the association of Lsm1-7 with RNA. Addition of MBP-PatMC enhanced the 110 RNA binding of Lsm1-7, while PatC showed no effect ( Fig. 1D,E) . Importantly, PatMC 111 alone bound oligoA RNA weakly, indicating the enhancement of RNA binding was due 112 to enhancement of Lsm1-7 RNA binding. This effect was specific to oligoA, as Pat1 did 113 not enhance binding to a U15 probe ( Fig. S1A-C) . To test if PatC's failure to enhance 114 RNA binding of Lsm1-7 was simply due to an inability to form a PatC/Lsm1-7 complex, 115
we incubated PatC and Lsm1-7 together and were unable to observe a stable complex 116 by analytical size exclusion chromatography ( Fig. S2A,B ). This indicates that the 117 PatC/Lsm1-7 interaction is likely weak and that the middle domain of Pat1 is required to 118 enhance RNA binding of Lsm1-7 in part by promoting formation a stable 119 heterooctameric complex. 120 121 Previous crystal structures have identified conserved residues on PatC that contact the 122 Lsm2/3 subunits, and when mutated, lead to loss of complex formation and defects in 123 mRNA degradation in budding yeast ( Fig. 1F) (27, 28) . Introducing these mutations into 124
SpPatMC (L457A/E461K) minimally affected its association with Lsm1-7, as shown by 125
The middle domain of Pat1 could enhance RNA binding of Lsm1-7 by directly binding 136 RNA, promoting a stable complex formation with Lsm1-7, or through both mechanisms. 137
We first sought to identify which domain of Pat1 could associate with Lsm1-7. A 138 construct containing most of the middle domain of Pat1, specifically residues 296-431, 139 was necessary and sufficient to interact with Lsm1-7, while PatC was unable to form a 140 stable complex by pull-down analysis (Fig. 2) . This suggests the middle domain of Pat1 141 is responsible for promoting a stable complex with Lsm1-7. 142
143
We wanted to distinguish if the middle domain was only involved in protein-protein 144 interactions or had additional roles in promoting RNA binding. To test these possibilities, 145
we purified a series of N-terminal truncations of Pat1 and surveyed their ability to 146 associate with Lsm1-7 by pull-down assays ( Fig. 2A,B , truncations 1-4). Deletion of 147 residues 296-431 abolished the Pat1/Lsm1-7 interaction, indicating that these residues 148 are involved in associating with Lsm1-7 (truncation 3). This identifies residues in the 149 middle domain of Pat1 that are required to form a stable complex with Lsm1-7. 150 151 Because we identified two N-terminal truncations of Pat1 that retained the ability to 152 interact with Lsm1-7 to similar extent, we tested if these could enhance RNA binding of 153 the PatMC/Lsm1-7 complex ( Fig. 2A,B , truncations 1 and 2). If the sole function of the 154 middle domain is to promote association with Lsm1-7, then all N-terminal truncations 155 that interact with Lsm1-7 should enhance RNA binding. Contrary to this expectation, we 156 found Pat1 317-754 was unable to stimulate RNA binding ( Fig. 2C,D) . This suggests 157 that PatMC contains a region that is dispensable for PatMC/Lsm1-7 complex formation 158 but essential for enhancing RNA binding. The binding isotherm for Pat1 317-754 is 159 identical to the Lsm1-7/PatMC L457A/E461K mutant complex, which can also interact 160 with Lsm1-7 but fails to enhance RNA binding ( Fig. 1B,C,E) . We therefore reason that 161 residues 296-316 of Pat1 must be involved in stabilizing a productive complex that can 162 bind RNA with high affinity, which we term the 'Lsm Activation Region' (LAR). The LAR 163 is highly conserved in the Schizosaccharomyces genus, which is characteristic of short 164 linear motifs that can be rapidly transferred between proteins during evolution ( Fig. 2E ) 165 (18). Metazoans have gained additional residues in this region, though we envision the 166 LAR is still required for Lsm1-7 activation in higher order eukaryotes ( Fig. S3) . 167
168
Our pulldown analysis and functional studies suggest that residues 317-342 in the 169 middle domain of Pat1 are important for promoting a stable PatMC/Lsm1-7 complex. 170
Sequence alignments reveal this region is conserved in Pat1 from yeast to humans 171 ( Fig. 3A) . To determine if this motif is necessary for the interaction of Pat1 with Lsm1-7, 172
we constructed series of internal PatMC deletions by replacing intervening residues with 173 a flexible (GS)3 linker ( Fig. 3B) . Because appending the conserved motif containing 174 amino acids 317-342 of the middle domain to PatC stabilized the interaction with Lsm1-175 7 ( Fig. 3C) , we refer to this region of Pat1 as the Lsm binding motif (LBM). In contrast, 176 deletion of the LAR was dispensable for Pat1/Lsm1-7 interactions. While we cannot 177 exclude that additional regions of Pat1 help stabilize the Pat1/Lsm1-7 complex, this data 178 suggests the LBM helps mediate the protein-protein interaction with the Lsm1-7 ring. 179
We conclude the middle domain of Pat1 contains two short linear motifs that may 180 function separately in stabilizing the PatMC/Lsm1-7 complex and a conformation that is 181 productive for RNA binding. effects on kmax, we saw a ~3-fold reduction in Km ( Fig. 5E-F ). This suggests that PatMC 220 can bind to HLMs in Dcp2 to enhance substrate binding of the decapping complex. 221
222
While SpPatC had no effect on decapping in vitro, we hypothesized that, like the Lsm1-223 7 complex, both the middle domain and C-terminal domains of Pat1 may cooperate to 224 enhance the activity of Dcp1/Dcp2. Studies of human PatC identified a basic patch that 225 is required for mRNA decapping and decay (38). Modeling of SpPatC onto existing 226 crystal structures reveals a similar basic patch to that identified in humans, which we 227 reasoned may be involved in activating Dcp2 (Fig. 5B) . Mutation of these four basic 228 residues to alanine (K453A/K454A/K530A/R533A, referred to as 4x Mutant) in 229
SpPatMC abolished its ability to activate Dcp1/Dcp2 (Fig. 5C) In addition to HLMs, the C-terminal region of Dcp2 contains inhibitory elements that 236 promote nonproductive binding of Dcp1/Dcp2 to substrate to limit catalysis ( Fig. 4A) . 237
Other HLM binding proteins, such as Edc3, have been shown to relieve autoinhibition 238 (17). To interrogate how PatMC activates an autoinhibited Dcp1/Dcp2, we determined 239 the kinetic parameters of an extended Dcp1/Dcp2 construct that contains both inhibitory 240 elements and HLMs (Dcp1/Dcp2 1-504, termed Dcp1/Dcp2Ext), either alone or with 241 saturating amounts of PatMC. Unlike the Dcp1/Dcp2HLM1/2, PatMC activated the catalytic 242 step of decapping, while also decreasing the affinity of Dcp1/Dcp2Ext for substrate ( Fig.  243 5A, C-D). This suggests that Dcp1/Dcp2Ext binds nonproductively to RNA, and PatMC 244 activates catalysis at the expense of substrate binding. This is in agreement with HLM 245 binding proteins relieving autoinhibition to promote decapping, suggesting this may be a 246 general model for proteins that bind the C-terminus of Dcp2. We conclude Pat1 uses its 247 decapping and ensure transcript specificity in cells. We show that Pat1 directly activates 287 decapping by binding helical leucine rich motifs (HLMs) in the C-terminal regulatory 288 region to enhance Dcp1/Dcp2 RNA binding and alleviate autoinhibition (Figs. 4-5) . This 289 mechanism is reminiscent of other HLM binding proteins, such as Edc3, and may be a 290 general mechanism by which HLM binding proteins promote decapping. Importantly the 291 middle domain and structured C-terminus are both required for these effects. This is where n represents the Hill coefficient. Plots and fits were generated using in house 366 scripts written in R, which are available upon request. 367 368
Cloning and Protein Purification 369
All seven Lsm genes were codon optimized for expression in E.coli and synthesized as 370 polycistronic gene (IDT). The genes were in order from Lsm1 to Lsm7, where each 371 gene was separated by a 28nucleotide spacer followed by a ribosome binding site. The 372 polycistron was cloned into a vector with an His6-TEV site on the N-terminus of Lsm1. 373
Unless stated otherwise, proteins were purified in BL21(DE3)* in LB media. Cells were 374 grown to OD600=0.6 at 37 °C. IPTG was added to 1 mM and cells were grown shaking 375 overnight at 17 °C. Cell pellets were harvested by centrifugation and lysed in 376 appropriate buffer. For Lsm1-7, cells were lysed in Buffer A (2 M NaCl, 20 mM HEPES, 377 20 mM Imidazole, 5 mM βME, protease inhibitor, lysozyme, pH=7.5) by sonication. 378 were TEV cleaved overnight. We found the MBP tag to be essential for purification of all 394 Pat1 constructs that contained the middle domain, so it was not removed. Elutants were 395 concentrated and further purified by S200 16/60 in SEC buffer. Peak fractions were 396 pooled and concentrated before being flash frozen. 10µM Lsm1-7 were mixed and incubated at room temperature for 15 minutes before 430 being added to pre-equilibrated amylose beads (New England Biolabs) for 5 minutes. 431
The beads were spun down at 4000g for 2 minutes and samples were washed four 432 times with 500 µl SEC buffer before being eluted with 30 µl SEC buffer supplemented 433 Lanes that had Lsm1 intensities below background were adjusted to zero. We chose to 444 quantify only Lsm1 band, as commassie staining is nonlinear and decreases with the 445 molecular weight of the protein. 446 447
Fission yeast strain construction and growth assays: 448
All strains were constructed by knocking in C-terminally tagged superfolderGFP Pat1 449 constructs into the commercially available pat1::KanMX background (Bioneer). A list of 450 strains used in this study are provided in Table S1 . All Pat1 constructs were cloned with 451 a C-terminal superfolderGFP tag and Ura4 3' UTR and cloned into a pUC-19 vector 452 containing 500basepairs upstream and downstream of the Pat1 locus with a 453
Hygromycin resistance cassette (45). Plasmids were linearized with restriction enzymes 454 and knocked into the ∆Pat1 background by standard procedures (46). To verify knock in 455 at the correct genomic locus DNA was obtained by phenol:cholorom extraction and 456 tested for presence of correct genomic insertion by PCR. Colonies containing the knock 457 in at the correct locus were stored as glycerol stocks at -80 ºC. For plate growth assays, 458 yeast strains were grown overnight in YES and diluted to OD600 = 0.115 and serially 459 diluted 4-fold before being spotted onto YES plates and grown for ~1.5 days at 30 ºC. 460
461
For western blots, cells were grown overnight and diluted to OD600 = 1 the following day. 462
Cells were pelleted by centrifugation and protein was extracted with 2M NaOH/10mM 463 BME supplemented with a protease inhibitor tablet (Roche). 55% Trichloroacetic acid 464 was then added to precipitate protein, and then centrifuged at 16,000rpm for 20 minutes 465 at 4 ºC. The supernatant was removed and the pellet was resuspended in HUE buffer 466 (8M Urea, 1%SDS, 50mM EDTA, 10mM BME) and heated to 70 ºC for 15 minutes 467 before flash freezing and storing at -80 ºC. Western blots for protein expression were two conserved regions involved in decapping factor recruitment. PLoS One 9(5). 
